Search results

Search Web pagesPDFs

Results will auto-populate based on filter selection.

Filters
Forms
News Release
Operational Policy Manual
(-) Page
Keywords
FAQ
Forms
Provider profile
Found 626 result(s)
Drug formulary listing decision – Calcitonin Gene-Related Peptide Monoclonal Antibodies in prevention of migraine
Indication Prevention of migraine in adults who have at least four migraine days per month. Formulary Status The WSIB Drug Advisory Committee (DAC) recommended that…
Drug formulary listing decision – Compounded topical analgesics
Indication(s)Compounded topical analgesics have not been approved by Health Canada and thus have no official indication for the topical treatment of pain.Formulary statusThe…
Drug formulary listing decision – Corticosteroid injections in musculoskeletal conditions
Corticosteroid injections in musculoskeletal conditions Indications/Clinical uses Treatment of acute and chronic musculoskeletal conditions including neck and upper…
Drug formulary listing decision – Desvenlafaxine
Indication(s)Symptomatic relief of major depressive disorder (MDD).DAC recommendationThe Drug Advisory Committee (DAC) has recommended that desvenlafaxine not be listed on…
Drug formulary listing decision – Diclofenac sodium solution 1.5%
Indication (s)Treatment of symptoms associated with osteoarthritis of the knee (duration of treatment not to exceed 3 months).DAC recommendationThe Drug Advisory Committee (…